{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:20:45Z","timestamp":1761862845967,"version":"build-2065373602"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.rdc.2009.03.005","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T05:12:38Z","timestamp":1243487558000},"page":"111-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Hepatitis C\u2013Associated Rheumatic Disorders"],"prefix":"10.1016","volume":"35","author":[{"given":"Dan","family":"Buskila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rdc.2009.03.005_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.rdc.2009.03.005_bib2","first-page":"447","article-title":"Extrahepatic manifestations in patients with chronic hepatitis C virus infection","volume":"17","author":"Ramos-Casals","year":"2005","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2009.03.005_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11894-006-0064-y","article-title":"Extrahepatic manifestations of hepatitis C virus","volume":"8","author":"Sterling","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"issue":"4","key":"10.1016\/j.rdc.2009.03.005_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00002281-200007000-00011","article-title":"Hepatitis C-associated arthritis","volume":"12","author":"Buskila","year":"2000","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2009.03.005_bib5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jbspin.2006.05.005","article-title":"Rheumatologic manifestations of chronic hepatitis C infection","volume":"73","author":"Lormeau","year":"2006","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.rdc.2009.03.005_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2796.2005.01490.x","article-title":"Systemic autoimmune diseases coexisting with chronic hepatitis C virus infection (the HIS PAMEC Registry): patterns of clinical and immunological expression in 180 cases","volume":"257","author":"Ramos-Casals","year":"2005","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.rdc.2009.03.005_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0049-0172(98)80043-7","article-title":"Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus-infected Israeli patients","volume":"28","author":"Buskila","year":"1998","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2009.03.005_bib8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/rheumatology\/keh668","article-title":"Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon","volume":"44","author":"Nissen","year":"2005","journal-title":"Rheumatology"},{"issue":"48","key":"10.1016\/j.rdc.2009.03.005_bib9","first-page":"6518","article-title":"Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients","volume":"13","author":"Stefanova-Petrova","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.rdc.2009.03.005_bib10","first-page":"979","article-title":"Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis","volume":"23","author":"Lovy","year":"1996","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2009.03.005_bib11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ard.57.12.728","article-title":"Cryoglobulinemia and rheumatic manifestations in patients with hepatitis C virus infection","volume":"57","author":"Lee","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"Suppl","key":"10.1016\/j.rdc.2009.03.005_bib12","first-page":"S200","article-title":"Musculoskeletal symptoms associated with hepatitis C","volume":"38","author":"Moder","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2009.03.005_bib13","first-page":"591","article-title":"Rheumatologic and autoimmune manifestations in patients with chronic hepatitis C virus infection","volume":"89","author":"Romero Portales","year":"1997","journal-title":"Rev Esp Enferm Dig"},{"issue":"10","key":"10.1016\/j.rdc.2009.03.005_bib14","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2009.03.005_bib15","first-page":"420","article-title":"Arthritis in patients with chronic hepatitis C virus infection","volume":"26","author":"Rivera","year":"1999","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2009.03.005_bib16","first-page":"579","article-title":"Hepatits C virus-related arthritis: characteristics and response to therapy with interferon alpha","volume":"18","author":"Zuckerman","year":"2000","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2009.03.005_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.semarthrit.2003.12.006","article-title":"The case for hepatitis C arthritis","volume":"33","author":"Rosner","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2009.03.005_bib18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00063030-200115090-00002","article-title":"Management of hepatitis C virus-related arthritis","volume":"15","author":"Zuckerman","year":"2001","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.rdc.2009.03.005_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0889-857X(02)00097-2","article-title":"Hepatitis C virus and arthritis","volume":"29","author":"Oliveri","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"issue":"8789","key":"10.1016\/j.rdc.2009.03.005_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0140-6736(92)91645-O","article-title":"Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease","volume":"339","author":"Haddad","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rdc.2009.03.005_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.md.0000157397.30055.c9","article-title":"Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases","volume":"84","author":"Ramos-Casals","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.rdc.2009.03.005_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.md.0000157398.37679.47","article-title":"Circulating monoclonal immunoglobulins in Sjogren syndrome: prevalence in 237 patients","volume":"84","author":"Brito-Zeron","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.rdc.2009.03.005_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/MEG.0b013e328010687d","article-title":"Chronic hepatitis C infection and sicca syndrome: a clear association with HLA DQB1\u221702","volume":"19","author":"Smyth","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.rdc.2009.03.005_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.autrev.2004.04.004","article-title":"Hepatitis C virus, Sjogren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer","volume":"4","author":"Ramos-Casals","year":"2005","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.rdc.2009.03.005_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","article-title":"Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage","volume":"106","author":"Lunel","year":"1994","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.rdc.2009.03.005_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ajh.20643","article-title":"Natural history and therapy of 66 patients with mixed cryoglobulinemia","volume":"81","author":"Bryce","year":"2006","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.rdc.2009.03.005_bib27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/rheumatology\/kem132","article-title":"Hepatitis C-associated mixed cryoglobulinemia: a crossroad between autoimmunity and lymphoproliferation","volume":"46","author":"Saadoun","year":"2007","journal-title":"Rheumatology"},{"issue":"5390","key":"10.1016\/j.rdc.2009.03.005_bib28","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.rdc.2009.03.005_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.autrev.2008.05.005","article-title":"Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?","volume":"8","author":"De Vita","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.rdc.2009.03.005_bib30","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.metabol.2008.04.023","article-title":"Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis","volume":"57","author":"Antonelli","year":"2008","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.rdc.2009.03.005_bib31","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1111\/j.1572-0241.2008.02040.x","article-title":"High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection","volume":"103","author":"Antonelli","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.rdc.2009.03.005_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.dld.2008.04.009","article-title":"CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinemia and hepatitis C","volume":"41","author":"Antonelli","year":"2009","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.rdc.2009.03.005_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2009.03.005_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.autrev.2008.07.023","article-title":"Etiology of fibromyalgia: the possible role of infection and vaccination","volume":"8","author":"Buskila","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.rdc.2009.03.005_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaut.2006.09.004","article-title":"Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle","volume":"27","author":"Ablin","year":"2006","journal-title":"J Autoimmun"},{"issue":"21","key":"10.1016\/j.rdc.2009.03.005_bib36","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/archinte.1997.00440420129014","article-title":"Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship","volume":"157","author":"Buskila","year":"1997","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.rdc.2009.03.005_bib37","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/rheumatology\/36.9.981","article-title":"Fibromyalgia-associated hepatitis C virus infection","volume":"36","author":"Rivera","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2009.03.005_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00042737-200105000-00008","article-title":"Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition","volume":"13","author":"Goulding","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.rdc.2009.03.005_bib39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00296-003-0290-7","article-title":"Fibromyalgia syndrome in patients with hepatitis C infection","volume":"23","author":"Kozanoglu","year":"2003","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.rdc.2009.03.005_bib40","first-page":"1118","article-title":"Lack of association of fibromyalgia with hepatitis C virus infection","volume":"32","author":"Narvaez","year":"2005","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2009.03.005_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10067-007-0737-4","article-title":"Hepatitis C virus infection in Italian patients with fibromyalgia","volume":"27","author":"Palazzi","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2009.03.005_bib42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2893.2002.00364.x","article-title":"Fatigue in patients with chronic hepatitis C","volume":"9","author":"Poynard","year":"2002","journal-title":"J Viral Hepat"},{"issue":"9","key":"10.1016\/j.rdc.2009.03.005_bib43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/096120339700600902","article-title":"Hepatitis C virus, autoimmunity and rheumatic disease","volume":"6","author":"Buskila","year":"1997","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.rdc.2009.03.005_bib44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/gut.45.3.435","article-title":"Prevalence of non-organ specific autoantibodies and chronic liver disease in the general population: a nested case control study of the Dionysos cohort","volume":"45","author":"Lenzi","year":"1999","journal-title":"Gut"},{"issue":"118","key":"10.1016\/j.rdc.2009.03.005_bib45","first-page":"404","article-title":"[Serological markers of arthritis in patients with chronic viral hepatitis]","volume":"20","author":"Dudek","year":"2006","journal-title":"Pol Merkur Lekarski"},{"issue":"4","key":"10.1016\/j.rdc.2009.03.005_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2893.1995.tb00026.x","article-title":"Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America","volume":"2","author":"Reddy","year":"1995","journal-title":"J Viral Hepat"},{"issue":"10","key":"10.1016\/j.rdc.2009.03.005_bib47","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.humimm.2007.06.008","article-title":"Anti \u2013C-reactive protein antibodies in chronic hepatitis C infection: correlation with severity and autoimmunity","volume":"68","author":"Kessel","year":"2007","journal-title":"Hum Immunol"},{"issue":"78","key":"10.1016\/j.rdc.2009.03.005_bib48","first-page":"1761","article-title":"Antiplatelet antibodies in patients with chronic viral hepatitis receiving interferon-alpha","volume":"54","author":"Christodoulou","year":"2007","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"10.1016\/j.rdc.2009.03.005_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10067-007-0783-y","article-title":"Anti SSB\/La antibody is negatively associated with HLA-DR2 in chronic hepatitis C infection","volume":"27","author":"Wu","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2009.03.005_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2008.07.027","article-title":"Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia","volume":"8","author":"Alpa","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.rdc.2009.03.005_bib51","first-page":"489","article-title":"Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection","volume":"32","author":"Lienesch","year":"2005","journal-title":"J Rheumatol"},{"issue":"36","key":"10.1016\/j.rdc.2009.03.005_bib52","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.3748\/wjg.v12.i36.5787","article-title":"Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alpha","volume":"12","author":"Gehring","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.rdc.2009.03.005_bib53","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1365-2893.2005.00642.x","article-title":"Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature","volume":"12","author":"Ramos-Casals","year":"2005","journal-title":"J Viral Hepat"},{"issue":"10","key":"10.1016\/j.rdc.2009.03.005_bib54","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2003.014175","article-title":"Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients","volume":"63","author":"Cervera","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2009.03.005_bib55","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1086\/382537","article-title":"Clinical features related to antiphospholipid syndrome in patients with chronic viral infection (hepatitis C virus\/HIV infection): description of 82 cases","volume":"38","author":"Ramos-Casals","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.rdc.2009.03.005_bib56","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1002\/1529-0131(200012)43:12<2801::AID-ANR21>3.0.CO;2-V","article-title":"Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus","volume":"43","author":"Ramos-Casals","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2009.03.005_bib57","first-page":"1473","article-title":"Hepatitis C virus infection in systemic lupus erythematosus: a case control study","volume":"30","author":"Perlemuter","year":"2003","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2009.03.005_bib58","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000441-200605000-00003","article-title":"Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus","volume":"331","author":"Ahmed","year":"2006","journal-title":"Am J Med Sci"},{"issue":"3\u20134","key":"10.1016\/j.rdc.2009.03.005_bib59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/B:MEBR.0000043982.17294.9b","article-title":"Hepatitis C virus-associated extrahepatic manifestations: a review","volume":"19","author":"Sene","year":"2004","journal-title":"Metab Brain Dis"},{"issue":"1","key":"10.1016\/j.rdc.2009.03.005_bib60","first-page":"109","article-title":"Systemic vasculitis in patients with hepatitis C","volume":"28","author":"Cacoub","year":"2001","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2009.03.005_bib61","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jcv.2004.10.003","article-title":"Polyarteritis nodosa after interferon treatment for chronic hepatitis C","volume":"32","author":"de Dios Garcia-Diaz","year":"2005","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.rdc.2009.03.005_bib62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2008.07.025","article-title":"Hepatitis C virus-related arthritis","volume":"8","author":"Palazzi","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"1 Suppl 48","key":"10.1016\/j.rdc.2009.03.005_bib63","first-page":"S39","article-title":"HCV infection: pathogenesis, clinical manifestations and therapy","volume":"26","author":"Antonelli","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2009.03.005_bib64","first-page":"2172","article-title":"Treatment of refractory symptomatic hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon alpha","volume":"27","author":"Zuckerman","year":"2000","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2009.03.005_bib65","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2004.10.031","article-title":"Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study","volume":"42","author":"Mazzaro","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.rdc.2009.03.005_bib66","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","article-title":"PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"52","author":"Cacoub","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2009.03.005_bib67","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1007\/s10620-006-9355-2","article-title":"Symptomatic and virological response to antiviral therapy in hepatitis C associated with extrahepatic complications of cryoglobulinemia","volume":"52","author":"Joshi","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.rdc.2009.03.005_bib68","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1196\/annals.1423.058","article-title":"Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection","volume":"1110","author":"Galeazzi","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"10.1016\/j.rdc.2009.03.005_bib69","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10067-006-0412-1","article-title":"Combination therapy with cyclosporine A and anti TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection","volume":"26","author":"Bellisai","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2009.03.005_bib70","first-page":"1353","article-title":"Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection","volume":"34","author":"Linardaki","year":"2007","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2009.03.005_bib71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00128071-200708030-00002","article-title":"Efficacy and safety of etanercept in psoriasis\/psoriatic arthritis: an updated review","volume":"8","author":"Romero-Mat\u00e9","year":"2007","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"10.1016\/j.rdc.2009.03.005_bib72","first-page":"1944","article-title":"Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection","volume":"35","author":"Ferri","year":"2008","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2009.03.005_bib73","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.autrev.2008.05.002","article-title":"Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases","volume":"8","author":"Cavazzana","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.rdc.2009.03.005_bib74","first-page":"421","article-title":"Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis","volume":"35","author":"Cansu","year":"2008","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2009.03.005_bib75","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel004","article-title":"Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinemia: efficacy and safety in the absence of steroids","volume":"45","author":"Quartuccio","year":"2006","journal-title":"Rheumatology (oxford)"},{"issue":"10","key":"10.1016\/j.rdc.2009.03.005_bib76","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2009.03.005_bib77","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1590-8658(07)80024-7","article-title":"Rituximab in mixed cryoglobulinemia: increased experience and perspectives","volume":"39","author":"De Vita","year":"2007","journal-title":"Dig Liver Dis"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X09000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X09000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:07:37Z","timestamp":1760180857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X09000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0889857X09000064"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2009.03.005","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C\u2013Associated Rheumatic Disorders","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2009.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}